Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning a Chimeric Ebola and Marburg Virus Glycoproteins Virus Like Particle Vaccine To Protect Against Diverse Ebola and Marburg Viruses, 20828 [2010-9150]

Download as PDF 20828 Federal Register / Vol. 75, No. 76 / Wednesday, April 21, 2010 / Notices Defense announces that the following Federal advisory committee meeting will take place: 1. Name of Committee: United States Military Academy Board of Visitors. 2. Date: Tuesday, May 11, 2010. 3. Time: 10:30 a.m.–1 p.m. Members of the public wishing to attend the meeting must notify Ms. Joy A. Pasquazi no later than May 6, 2010 at joy.pasquazi@us.army.mil or (845) 938– 5078 in order to have their name included on the attendance list. Photo identification may be required in order to gain access to the meeting location. All participants may be subject to security screening. 4. Location: Meeting room location has not yet been secured and will be posted in the Federal Register and on the Board of Visitors Web page, https:// www.usma.edu/bov.asp, when it becomes available. 5. Purpose of the Meeting: This is the 2010 Spring Meeting of the USMA Board of Visitors (BoV). Members of the Board will be provided updates on Academy issues. 6. Agenda: The Academy leadership will provide the Board updates on the following: Military Program, Physical Program, Intercollegiate Athletics, FY2010 Budget and Program Objective Memorandum (POM) 10–15. The Board will discuss meeting dates for the 2010 Summer and Annual Meetings, and receive updates on USMA upcoming events. 7. Public’s Accessibility to the Meeting: Pursuant to 5 U.S.C. 552b and 41 CFR 102–3.140 through 102–3.165, and the availability of space, this meeting is open to the public. Seating is on a first-come basis. 8. Committee’s Designated Federal Officer or Point of Contact: Ms. Joy A. Pasquazi, (845) 938–5078, Joy.Pasquazi@us.army.mil. Any member of the public is permitted to file a written statement with the USMA Board of Visitors. Written statements should be sent to the Designated Federal Officer (DFO) at: United States Military Academy, Office of the Secretary of the General Staff (MASG), 646 Swift Road, West Point, NY 10996–1905 or faxed to the Designated Federal Officer (DFO) at (845) 938–3214. Written statements must be received no later than five working days prior to the next meeting in order to provide time for member consideration. By rule, no member of the public attending open meetings will be allowed to present questions from the floor or speak to any issue under consideration by the Board. erowe on DSK5CLS3C1PROD with NOTICES SUPPLEMENTARY INFORMATION: VerDate Nov<24>2008 14:33 Apr 20, 2010 Jkt 220001 FOR FURTHER INFORMATION CONTACT: Ms. Joy A. Pasquazi, (845) 938–5078, (Fax: 845–938–3214) or via e-mail: Joy.Pasquazi@us.army.mil. Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2010–9148 Filed 4–20–10; 8:45 am] BILLING CODE 3710–08–P DEPARTMENT OF DEFENSE Department of the Army Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Active Topical Skin Protectants Department of the Army, DoD. Notice. AGENCY: ACTION: DEPARTMENT OF DEFENSE Department of the Army Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning a Chimeric Ebola and Marburg Virus Glycoproteins Virus Like Particle Vaccine To Protect Against Diverse Ebola and Marburg Viruses AGENCY: ACTION: Department of the Army, DoD. Notice. SUMMARY: Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 61/338,967, entitled ‘‘A Chimeric Ebola and Marburg Virus Glycoproteins Virus Like Particle Vaccine To Protect Against Diverse Ebola and Marburg Viruses.’’ The United States Government, as represented by the Secretary of the Army, has rights to this invention. Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. ADDRESSES: FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619–6664, both at telefax (301) 619–5034. The invention relates to a chimeric Ebola and Marburg virus glycoproteins virus like particle vaccine and its use to protect against highly fatal diverse Ebola and Marburg viruses, in which no vaccine or proven countermeasure exists. SUMMARY: Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 09/871,743, entitled ‘‘Active Topical Skin Protectants,’’ filed June 1, 2001, which issued on October 29, 2002 as U.S. Patent No. 6,472,437. The United States Government, as represented by the Secretary of the Army, has rights to this invention. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619–6664, both at telefax (301) 619–5034. SUPPLEMENTARY INFORMATION: The invention relates to a topical skin protectant formulation containing a barrier cream and an active moiety for protecting warfighters and civilians against all types of harmful chemicals, specifically chemical warfare agents (CWAs). The topical skin protectant offers a barrier property and an active moiety that serves to neutralize chemical warfare agents into less toxic agents. Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2010–9149 Filed 4–20–10; 8:45 am] BILLING CODE 3710–08–P SUPPLEMENTARY INFORMATION: Brenda S. Bowen, Army Federal Register Liaison Officer. DEPARTMENT OF DEFENSE Department of the Army Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Perfactant Pulmonary Lavage Department of the Army, DoD. Notice. [FR Doc. 2010–9150 Filed 4–20–10; 8:45 am] AGENCY: BILLING CODE 3710–08–P ACTION: PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 E:\FR\FM\21APN1.SGM 21APN1

Agencies

[Federal Register Volume 75, Number 76 (Wednesday, April 21, 2010)]
[Notices]
[Page 20828]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-9150]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning a Chimeric Ebola and 
Marburg Virus Glycoproteins Virus Like Particle Vaccine To Protect 
Against Diverse Ebola and Marburg Viruses

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Patent Application Serial No. 61/338,967, 
entitled ``A Chimeric Ebola and Marburg Virus Glycoproteins Virus Like 
Particle Vaccine To Protect Against Diverse Ebola and Marburg 
Viruses.'' The United States Government, as represented by the 
Secretary of the Army, has rights to this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Applications (ORTA), (301) 619-
6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to a chimeric Ebola 
and Marburg virus glycoproteins virus like particle vaccine and its use 
to protect against highly fatal diverse Ebola and Marburg viruses, in 
which no vaccine or proven countermeasure exists.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2010-9150 Filed 4-20-10; 8:45 am]
BILLING CODE 3710-08-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.